Similar Papers

Paper Title
Journal
Date
Author
Minimally invasive surgical therapies for benign prostatic hyperplasia in the geriatric population: A systematic review.
Ahmad Abid ... Alexander Small
The Prostate | VOL. 84
Ahmad Abid, et. al.Ahmad Abid ... Alexander Small
24 Apr 2024
(212) Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia in the Geriatric Population: A Systematic Review
A Abid ... H Piperdi
The Journal of Sexual Medicine | VOL. 21
A Abid, et. al.A Abid ... H Piperdi
05 Feb 2024
MP13-08 HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) OUTCOMES AFTER MINIMALLY INVASIVE SURGICAL THERAPIES (MIST) FOR BPH
Mark Assmus ... Nick Dean
Journal of Urology | VOL. 209
Mark Assmus, et. al.Mark Assmus ... Nick Dean
01 Apr 2023
I Can’t Get No Satisfaction: Patient-reported Outcomes After Different Treatment Options for Lower Urinary Tract Symptoms
Christina Sze ... Steven A Kaplan
European Urology Focus | VOL. 8
Christina Sze, et. al.Christina Sze ... Steven A Kaplan
01 Mar 2022
View more papers

More From: Uro-Technology Journal

Paper Title
Journal
Date
Author
Does laparoscopy still have a role in the era of robotic surgery?
Francesco Greco
Uro-Technology Journal | VOL. -
Francesco GrecoFrancesco Greco
23 Dec 2024
The effects of 5-ARIs on prostate volume in patients with or without heart failure and benign prostate hyperplasia: prospective, comparative study
Denis V Krakhotkin ... Volodymyr A Chernylovskyi
Uro-Technology Journal | VOL. 8
Denis V Krakhotkin, et. al.Denis V Krakhotkin ... Volodymyr A Chernylovskyi
24 Sep 2024
The use of 5 alpha-reductase in the era of minimally invasive surgical therapies (MISTs): Is it still valuable?
Francesco Greco ... Luigi D Omanico
Uro-Technology Journal | VOL. 8
Francesco Greco, et. al.Francesco Greco ... Luigi D Omanico
24 Sep 2024
Neoadjuvant chemotherapy should only be considered in patients with cT3-T4a muscle-invasive bladder cancer
Sytse C Van Beek ... Noor Van Ginkel
Uro-Technology Journal | VOL. 8
Sytse C Van Beek, et. al.Sytse C Van Beek ... Noor Van Ginkel
23 Sep 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.